DAA uptake improves but new strategies needed in PWID

Use of direct-acting antivirals (DAAs) in people who inject drugs (PWID) has increased markedly in the era of unrestricted access to the drugs, however uptake remains suboptimal at just 38%. An observational cohort study of 853 PWID from 16 community-based sites in NSW and Queensland found 45% had detectable HCV RNA on enrolment, consistent with ...

Already a member?

Login to keep reading.

© 2021 the limbic